Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCannBioRx Life Sciences Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.85 | $0 | |||
| 08/12/2024 | Q2 2024 | $0.01 | $0 | |||
| 05/15/2024 | Q1 2024 | -$1.68 | $0 | |||
| 04/29/2024 | Q4 2023 | -$1.97 | $166,030 | |||
| 11/09/2023 | Q3 2023 | -$24.56 | $0 | |||
| 08/15/2023 | Q2 2023 | -$13.38 | $0 | |||
| 05/15/2023 | Q1 2023 | -$24.17 | $0 | |||
| 04/28/2023 | Q4 2022 | -$185.83 | $0 | |||
| 11/10/2022 | Q3 2022 | -$208.61 | $0 | |||
| 08/09/2022 | Q2 2022 | $32.74 | $0 | |||
| 05/16/2022 | Q1 2022 | $17.45 | $0 | |||
| 03/30/2022 | Q4 2021 | $11.60 | $0 | |||
| 11/12/2021 | Q3 2021 | $212.44 | $0 | |||
| 08/16/2021 | Q2 2021 | -$286.09 | $0 | |||
| 07/16/2021 | Q1 2021 | -$221.90 | $0 | |||
| 07/09/2021 | Q4 2020 | -$156.27 | $0 | |||
| 11/23/2020 | Q3 2020 | -$18.85 | $0 | |||
| 08/19/2020 | Q2 2020 | $6.03 | $0 | |||
| 05/22/2020 | Q1 2020 | -$54.12 | $0 | |||
| 04/07/2020 | Q4 2019 | -$308.35 | $0 |
CannBioRx Life Sciences Corp. Earnings: FAQ's
When is CannBioRx Life Sciences Corp.'s earnings date?
CannBioRx Life Sciences Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates.
How can I listen to CannBioRx Life Sciences Corp.'s earnings conference
call?
The conference call for CannBioRx Life Sciences Corp.'s latest earnings report can be listened to online.
How can I read CannBioRx Life Sciences Corp.'s conference call transcript?
The conference call transcript for CannBioRx Life Sciences Corp.'s latest earnings report can be read online.
How much profit does CannBioRx Life Sciences Corp. generate each year?
CannBioRx Life Sciences Corp. (:ATNFW) has a recorded net income of $0. CannBioRx Life Sciences Corp. has generated $-52.6 earnings per share over the last four quarters.
What is CannBioRx Life Sciences Corp.'s price-to-earnings ratio?
CannBioRx Life Sciences Corp. (:ATNFW) has a price-to-earnings ratio of -0.89 and price/earnings-to-growth ratio is -0.01.